Why Pfizer (PFE) Could Win Your 2025 Portfolio
Pfizer (PFE) stock analysis reveals compelling opportunities for 2025 despite recent volatility. Currently trading at $27.08, the pharmaceutical giant shows strong fundamentals with $14.65 billion quarterly revenue and robust dividend…
